The Global injectable drug delivery is expected to reach USD 789.7 billion by 2024 from USD 330.6 billion in 2016, at a CAGR of 11.5% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Request for Sample Report @ http://databridgemarketresearch.com/request-a-sample/?chalet=global-injectable-drug-delivery-market

The major factors driving the growth of this market are the increasing use of biologics, rising prevalence of chronic diseases, increasing occurrence of needle-stick injuries, and the benefits of injections (convenience, ease of use, and reduced pain). These factors increase the demand for devices such as safety syringes, prefilled syringes, and auto-disabled syringes. On the other hand, safety concerns regarding the use of injectables, increased risk of blood-borne infections due to injectables, and presence of other drug delivery methods (such as oral and transdermal) may hinder the growth of the market.
The global injectable drug delivery market is segmented on the basis of type, product type, application, usage pattern, mode of administration, end user, distribution channel, and geography.

Browse Full Report with Details TOC @ http://databridgemarketresearch.com/reports/pharmaceutical/global-injectable-drug-delivery-market/

On the basis of application, the market is segmented into autoimmune disease, hormonal disorders, orphan diseases, oncology and others.

On the basis of usage pattern, the market is segmented into curative care, immunization and other usage pattern.

On the basis of mode of administration, the market is segmented into skin, circulatory/muskoskeletal, organs and central nervous system.

On the basis of end users, the market is classified into hospitals and clinics, home healthcare, research laboratories, pharmaceutical and biotechnological companies and others. In 2017, the hospital &clinics segment is expected to dominate the market and is expected to continue this trend till 2024.

Based on geography, the market is segmented into five geographical regions:
• North America
• Europe
• Asia-Pacific
• South America
• Middle East and Africa.

The geographical regions are further segmented into 29 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and others.

Some of the major players operating in this market are
• Baxter International, Inc.
• Becton Dickinson and Company
• Gerresheimer AG
• Pfizer, Inc.
• Schott AG
• Alkermes Plc.
• Eli Lilly and Company
• Sandoz, Terumo Corporation
• Teva Pharmaceuticals Industries Ltd.
• Bespak
• Antares Pharma
• Elcam Medical
• Haselmeier
• Mylan N.V.
• Novo Nordisk
• Owen Mumford Ltd
• Sanofi, West Pharmaceutical Services, Inc
• Ypsomed Holding AG

Inquiry before Buying @ http://databridgemarketresearch.com/inquire-before-buying/?chalet=global-injectable-drug-delivery-market

Related Report

Global Diabetes Care Devices Market – Industry Trends and Forecast to 2024

Global Diabetes Care Devices Market, By Product Type, By End-User, By Distribution Channel, By Geography (North America, Europe, Asia-Pacific, South America and Middle East and Africa) – Industry Trends and Forecast to 2024

http://databridgemarketresearch.com/reports/pharmaceutical/global-diabetes-care-devices-market/

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Ankit Singh
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]
Investor: [email protected]
Visit Blog http://databridgemarketresearch.com/blog/